Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease.

Journal of Neural Transmission
Isis A ZainaghiOrestes V Forlenza

Abstract

Studies have shown that platelet APP ratio (representing the percentage of 120-130 kDa to 110 kDa isoforms of the amyloid precursor protein) is reduced in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD). In the present study, we sought to determine if baseline APP ratio predicts the conversion from MCI to AD dementia after 4 years of longitudinal assessment. Fifty-five older adults with varying degrees of cognitive impairment (34 with MCI and 21 with AD) were assessed at baseline and after 4 years. MCI patients were re-classified according to the conversion status upon follow-up: 25 individuals retained the diagnostic status of MCI and were considered as stable cases (MCI-MCI); conversely, in nine cases the diagnosis of dementia due to AD was ascertained. The APP ratio (APPr) was determined by the Western blot method in samples of platelets collected at baseline. We found a significant reduction of APPr in MCI patients who converted to dementia upon follow-up. These individuals had baseline APPr values similar to those of demented AD patients. The overall accuracy of APPr to identify subjects with MCI who will progress to AD was 0.74 ± 0.10, p = 0.05. The cut-off of 1.12 yielded a sensitivity of 75 % ...Continue Reading

References

Feb 1, 1997·Archives of Neurology·R N RosenbergM F Weiner
Mar 1, 1997·Neurobiology of Aging·T A DaviesE R Simons
Dec 26, 2001·Archives of Neurology·R C PetersenB Winblad
Jun 12, 2002·Archives of Neurology·Domenico PraticòJohn Q Trojanowski
Jul 12, 2002·Annals of Neurology·R M Damian HolsingerGeneviève Evin
Apr 17, 2004·Journal of Neural Transmission·W F GattazC M C Bottino
Nov 1, 2005·Journal of the Neurological Sciences·Kun TangRoger N Rosenberg
Jan 15, 2009·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Breno Satler DinizOrestes Vicente Forlenza
May 19, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·T T SeppäläT Pirttilä
May 25, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Orestes Vicente ForlenzaWagner Farid Gattaz
Jun 26, 2010·Journal of Psychiatric Research·Orestes V ForlenzaWagner F Gattaz
Oct 12, 2010·Journal of Alzheimer's Disease : JAD·Breno Satler DinizOrestes Vicente Forlenza
Oct 28, 2010·Expert Review of Neurotherapeutics·Linda K McEvoy, James B Brewer
Dec 24, 2010·BMC Medicine·Orestes V ForlenzaWagner F Gattaz
Jan 1, 2011·Translational Psychiatry·M OrešičH Soininen

❮ Previous
Next ❯

Citations

Nov 28, 2013·Molecular Diagnosis & Therapy·Ross W PatersonHenrik Zetterberg
Sep 25, 2014·Acta Neuropathologica·Michael VeitingerMaria Zellner
May 21, 2013·FEBS Letters·Natalia N Nalivaeva, Anthony J Turner
May 3, 2013·Thrombosis and Haemostasis·H F Langer, T Chavakis
Sep 8, 2015·Journal of Psychiatric Research·Kenia Kelly Fiaux do NascimentoBreno S Diniz
Jun 18, 2014·Acta Neuropathologica Communications·Michael VeitingerMaria Zellner
Oct 22, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Orestes V ForlenzaWagner Gattaz
Nov 1, 2013·World Journal of Psychiatry·Geneviève Evin, Qiao-Xin Li
Oct 11, 2017·Journal of Cellular and Molecular Medicine·José Javier LópezPedro Cosme Redondo
Nov 20, 2016·Journal of Alzheimer's Disease : JAD·Tamires Alves SarnoOrestes Vicente Forlenza
Apr 19, 2017·British Journal of Haematology·Maria Elisa Mancuso, Elena Santagostino
May 31, 2018·European Archives of Psychiatry and Clinical Neuroscience·Jessyka Maria de França BramOrestes Vicente Forlenza
May 31, 2018·Journal of Alzheimer's Disease : JAD·Oluwatomi E S AkingbadeElizabeta B Mukaetova-Ladinska
Mar 25, 2020·Dementia & Neuropsychologia·Gustavo Alves Andrade Dos Santos, Paulo Celso Pardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Related Papers

Alzheimer Disease and Associated Disorders
Barbara BorroniAlessandro Padovani
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
Inez H G B RamakersFrans Verhey
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Barbara BorroniAlessandro Padovani
© 2021 Meta ULC. All rights reserved